PreveCeutical Medical Inc. (PRVCF)
OTCMKTS · Delayed Price · Currency is USD
0.0161
+0.0018 (12.59%)
Feb 12, 2026, 10:16 AM EST

PreveCeutical Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
9910101012
Market Cap Growth
-9.46%-7.12%2.48%-2.18%-12.76%152.73%
Enterprise Value
121213121214
Last Close Price
0.020.020.020.020.020.02
PB Ratio
-1.65-2.04-2.32-2.89-3.12-4.10
P/FCF Ratio
-----228.57
P/OCF Ratio
-----228.57
EV/FCF Ratio
-13.44----271.00
Debt / Equity Ratio
-0.62-0.67-0.67-0.71-0.71-0.84
Debt / FCF Ratio
-----46.64
Net Debt / Equity Ratio
-0.61-0.66-0.67-0.71-0.71-0.79
Net Debt / EBITDA Ratio
-1.68-5.93-4.30-3.20-3.51-1.37
Net Debt / FCF Ratio
-3.58-10.27-13.11-14.76-6.8344.22
Quick Ratio
0.020.010.000.010.030.12
Current Ratio
0.040.020.010.010.030.13
Return on Assets (ROA)
-368.89%-231.04%-308.69%-369.59%-225.09%-225.55%
Return on Capital Employed (ROCE)
36.70%11.40%15.80%22.30%34.40%121.20%
Earnings Yield
-25.51%-8.67%-9.52%-11.07%-13.50%-25.75%
FCF Yield
-10.27%-3.16%-2.22%-1.66%-3.33%0.44%
Buyback Yield / Dilution
-3.42%-0.15%-2.59%-2.72%-11.43%-15.19%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.